Synthetic Genomics purchases patent portfolio from Febit Holding GmbH; accelerating work in biofuels and biochemicals, among others
Green Car Congress
SEPTEMBER 18, 2012
(SGI), a privately held company developing and commercializing genomic-driven solutions to solve a range of global challenges, has purchased from Febit Holding GmbH the worldwide rights to three families of patents and patent applications related to key synthetic genomic technologies. Craig Venter, Ph.D., Founder and CEO, SGI.
Let's personalize your content